Personalis, Inc. Shareholders' Equity
Personalis, Inc. (PSNL) had Shareholders' Equity of $235.16 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $235.16M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $254.76M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $261.19M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $171.41M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $235.16M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $254.76M 10-Q · filed 2026-08-04 |
| 2025-12-31 | $261.19M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $171.41M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $190.83M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $207.34M 10-Q · filed 2026-08-04 |
| 2024-12-31 | $202.96M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $166.76M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $112.27M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $120.69M 10-Q · filed 2025-08-05 |
| 2023-12-31 | $129.44M 10-K · filed 2026-02-26 |
| 2023-09-30 | $151.21M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $176.09M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $193.63M 10-Q · filed 2024-08-07 |
| 2022-12-31 | $218.14M 10-K · filed 2025-02-27 |
| 2022-09-30 | $242.40M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $264.63M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $286.71M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $310.30M 10-K · filed 2024-02-28 |
| 2021-09-30 | $325.30M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $338.75M 10-Q · filed 2022-11-02 |
| 2021-03-31 | $348.42M 10-Q · filed 2022-08-03 |
| 2020-12-31 | $194.94M 10-K · filed 2024-02-28 |
| 2020-09-30 | $203.54M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $93.12M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $99.20M 10-Q · filed 2021-08-04 |
| 2019-12-31 | $106.69M 10-K · filed 2023-02-23 |
| 2019-09-30 | $111.39M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $117.02M 10-Q · filed 2020-11-05 |
| 2019-03-31 | -$110.52M 10-Q · filed 2020-08-06 |
| 2018-12-31 | -$106.39M 10-K · filed 2022-02-24 |
| 2018-09-30 | -$103.29M 10-Q · filed 2019-11-13 |
| 2018-06-30 | -$100.80M 10-Q · filed 2019-08-13 |
| 2017-12-31 | -$92.60M 10-K · filed 2021-02-25 |
| 2016-12-31 | -$69.84M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |